BioSpace News Archive

Krystal Biotech, Inc., the leader in redosable gene therapy, announced that the Company will participate in the H.C. Wainwright 24th Annual Global Investment Conference in New York from September 12-14.

The report suggests that the rise in geriatric population, which is more susceptible to thrombosis events, globally, is likely to boost the demand for thrombosis drugs during the forecast period.

The C-reactive protein testing market is predicted to display sluggish growth over the forecast period of 2020 to 2030.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today presented detailed positive results from the second of two Phase 3 trials (PRIME) evaluating Dupixent® (dupilumab) in adults with uncontrolled prurigo nodularis in a late-breaking session at the European Academy of Dermatology and Venereology (EADV) 2022 Congress.

Allermi announced today that its direct-to-patient telehealth service to provide customized multi-ingredient nasal sprays for the relief of allergy symptoms is now available.

MaaT Pharma announced that Hervé Affagard, CEO and co-founder of MaaT Pharma, and Siân Crouzet, CFO of MaaT Pharma, will participate in three upcoming investor conferences.

Surgalign Holdings, Inc. announced two upcoming industry events it will be participating in and showcasing many of its latest spine and technology innovations.

argenx announced that during the extraordinary general meeting of shareholders held at 6:30pm CET, Mrs. Camilla Sylvest was appointed as non-executive director to its Board of Directors.

Cofactor Genomics, a Predictive Immune Modeling company, today presented initial results from the PREDAPT

InMed Pharmaceuticals Inc., a leader in the research, development and manufacturing of rare cannabinoids and cannabinoid analogs, announces an update on its research/development and commercial activities.